Stock Research for SGEN

SGEN

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

SGEN Stock Chart & Research Data

The SGEN chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the SGEN chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


SGEN Due diligence Resources & Stock Charts

The SGEN stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View SGEN Detailed Price Forecast - CNN Money CNN View SGEN Detailed Summary - Google Finance
Yahoo View SGEN Detailed Summary - Yahoo! Finance Zacks View SGEN Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View SGEN Trends & Analysis - Trade-Ideas Barrons View SGEN Major Holders - Barrons
NASDAQ View SGEN Call Transcripts - NASDAQ Seeking View SGEN Breaking News & Analysis - Seeking Alpha
Spotlight View SGEN Annual Report - CompanySpotlight.com OTC Report View SGEN OTC Short Report - OTCShortReport.com
TradeKing View SGEN Fundamentals - TradeKing Charts View SGEN SEC Filings - Bar Chart
WSJ View Historical Prices for SGEN - The WSJ Morningstar View Performance/Total Return for SGEN - Morningstar
MarketWatch View the Analyst Estimates for SGEN - MarketWatch CNBC View the Earnings History for SGEN - CNBC
StockMarketWatch View the SGEN Earnings - StockMarketWatch MacroAxis View SGEN Buy or Sell Recommendations - MacroAxis
Bullish View the SGEN Bullish Patterns - American Bulls Short Pains View SGEN Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View SGEN Stock Mentions - StockTwits PennyStocks View SGEN Stock Mentions - PennyStockTweets
Twitter View SGEN Stock Mentions - Twitter Invest Hub View SGEN Investment Forum News - Investor Hub
Yahoo View SGEN Stock Mentions - Yahoo! Message Board Seeking Alpha View SGEN Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for SGEN - SECform4.com Insider Cow View Insider Transactions for SGEN - Insider Cow
CNBC View SGEN Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for SGEN - OTC Markets
Yahoo View Insider Transactions for SGEN - Yahoo! Finance NASDAQ View Institutional Holdings for SGEN - NASDAQ


Stock Charts

FinViz View SGEN Stock Insight & Charts - FinViz.com StockCharts View SGEN Investment Charts - StockCharts.com
BarChart View SGEN Stock Overview & Charts - BarChart Trading View View SGEN User Generated Charts - Trading View




Latest Financial News for SGEN


A Look at Sage Therapeutics’ NMDA Receptor Portfolio
Posted on Friday September 21, 2018

As discussed earlier, Sage Therapeutics (SAGE) is focused on the development of products for the treatment of life-threatening central nervous system (or CNS) disorders. The products under development include SAGE-718 and SAGE-904.


Seattle Genetics Announces ADCETRIS® (Brentuximab Vedotin) Approval in Japan for Frontline Hodgkin Lymphoma
Posted on Friday September 21, 2018

-Approval Triggers Milestone Payment to Seattle Genetics of $10 Million-


Estimates and Recommendations for Shire on September 19
Posted on Friday September 21, 2018

Wall Street analysts expect Shire (SHPG) to report a 2.7% rise in revenue to ~$15.56 billion in 2018 compared to ~$15.16 billion in 2017. Analysts expect Shire’s net adjusted income to increase to $4.68 billion in 2018 compared to its net adjusted income of $4.60 billion in 2017. Shire’s stock price has risen nearly 15.4% in the last 12 months, and it’s risen ~15.7% year-to-date in 2018.


See what the IHS Markit Score report has to say about Seattle Genetics Inc.
Posted on Thursday September 20, 2018

Seattle Genetics Inc NASDAQ/NGS:SGEN


Stock Market & Investing Books

Enter a stock symbol to view the stock details.